Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C
Condition(s):Chronic Hepatitis CLast Updated:June 10, 2010Completed
Hide Studies Not Open or Pending
Condition(s):Chronic Hepatitis CLast Updated:June 10, 2010Completed
Condition(s):Acquired Immunodeficiency Syndrome; HIV InfectionsLast Updated:April 11, 2016Completed
Condition(s):Multiple Sclerosis, Relapsing-Remitting; Relapsing-Remitting Multiple SclerosisLast Updated:April 8, 2016Terminated
Condition(s):HIV-1 Infection; Immunosuppression-related Infectious DiseaseLast Updated:January 12, 2018Completed
Condition(s):EBV-Positive DLBCL, NosLast Updated:November 29, 2019Unknown status
Condition(s):Acquired Immunodeficiency Syndrome; HIV InfectionsLast Updated:November 19, 2018Completed
Condition(s):Primary ImmunodeficiencyLast Updated:April 10, 2020Withdrawn
Condition(s):Human Immunodeficiency Virus (HIV)Last Updated:October 10, 2023Completed
Condition(s):Hepatitis CLast Updated:July 7, 2017Completed
Condition(s):Glabellar Frown Lines and Canthal Lines and/or Horizontal Forehead Lines in the Upper FaceLast Updated:June 7, 2023Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.